BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37772555)

  • 21. Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric Cancer.
    Liu YP; Chen WD; Li WN; Zhang M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819869928. PubMed ID: 31530096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
    Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.
    Ren L; Deng H; Jiang Y; Liu C
    Dig Dis Sci; 2023 Apr; 68(4):1292-1305. PubMed ID: 36877334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.
    Zhou J; Peng S; Fan H; Li J; Li Z; Wang G; Zeng L; Guo Z; Lai Y; Huang H
    Cancer Med; 2023 Jun; 12(12):13471-13485. PubMed ID: 37119046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT.
    Bu X; Zhang A; Chen Z; Zhang X; Zhang R; Yin C; Zhang J; Zhang Y; Yan Y
    BMC Cancer; 2019 Oct; 19(1):976. PubMed ID: 31640627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
    Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
    Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting SALL4 by entinostat in lung cancer.
    Yong KJ; Li A; Ou WB; Hong CK; Zhao W; Wang F; Tatetsu H; Yan B; Qi L; Fletcher JA; Yang H; Soo R; Tenen DG; Chai L
    Oncotarget; 2016 Nov; 7(46):75425-75440. PubMed ID: 27705911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
    Yuan JH; Li WX; Hu C; Zhang B
    Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of PHF19 inhibits cell growth and migration in gastric cancer.
    Wang H; Xu P; Sun G; Lv J; Cao J; Xu Z
    Scand J Gastroenterol; 2020 Jun; 55(6):687-693. PubMed ID: 32449434
    [No Abstract]   [Full Text] [Related]  

  • 37. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
    Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
    Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
    Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
    J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.
    Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM
    J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.